UniProt ID | COMT_HUMAN | |
---|---|---|
UniProt AC | P21964 | |
Protein Name | Catechol O-methyltransferase | |
Gene Name | COMT | |
Organism | Homo sapiens (Human). | |
Sequence Length | 271 | |
Subcellular Localization |
Isoform Soluble: Cytoplasm. Isoform Membrane-bound: Cell membrane Single-pass type II membrane protein Extracellular side . |
|
Protein Description | Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol.. | |
Protein Sequence | MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLLMGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
81 | Phosphorylation | SVLEAIDTYCEQKEW HHHHHHHHHHHHHHH | 24.77 | 28796482 | |
82 | Phosphorylation | VLEAIDTYCEQKEWA HHHHHHHHHHHHHHH | 7.11 | 28796482 | |
86 | Ubiquitination | IDTYCEQKEWAMNVG HHHHHHHHHHHHHCC | 32.69 | - | |
88 | Ubiquitination | TYCEQKEWAMNVGDK HHHHHHHHHHHCCCC | 14.09 | 21890473 | |
89 | Ubiquitination | YCEQKEWAMNVGDKK HHHHHHHHHHCCCCC | 4.83 | 21890473 | |
90 | Sulfoxidation | CEQKEWAMNVGDKKG HHHHHHHHHCCCCCC | 4.35 | 30846556 | |
95 | Ubiquitination | WAMNVGDKKGKIVDA HHHHCCCCCCCCHHH | 58.45 | - | |
98 | Ubiquitination | NVGDKKGKIVDAVIQ HCCCCCCCCHHHHHH | 48.73 | - | |
119 | Glutathionylation | LLELGAYCGYSAVRM HHHHHCCCCHHHHHH | 4.01 | 22833525 | |
127 (in isoform 2) | Ubiquitination | - | 6.60 | 21890473 | |
128 (in isoform 2) | Ubiquitination | - | 27.15 | 21890473 | |
129 (in isoform 2) | Ubiquitination | - | 3.94 | 21890473 | |
131 | Phosphorylation | VRMARLLSPGARLIT HHHHHHCCCCCEEEE | 26.36 | 30266825 | |
145 | Glutathionylation | TIEINPDCAAITQRM EEEECCCHHHHHHHH | 2.65 | 22833525 | |
159 | 2-Hydroxyisobutyrylation | MVDFAGVKDKVTLVV HHHHCCCCCEEEEEE | 51.41 | - | |
159 | Succinylation | MVDFAGVKDKVTLVV HHHHCCCCCEEEEEE | 51.41 | 23954790 | |
159 | Ubiquitination | MVDFAGVKDKVTLVV HHHHCCCCCEEEEEE | 51.41 | - | |
169 | Phosphorylation | VTLVVGASQDIIPQL EEEEEECCCCHHHHH | 23.58 | 28348404 | |
177 | Ubiquitination | QDIIPQLKKKYDVDT CCHHHHHHHHCCCCC | 41.81 | 21906983 | |
177 (in isoform 1) | Ubiquitination | - | 41.81 | 21890473 | |
178 | Ubiquitination | DIIPQLKKKYDVDTL CHHHHHHHHCCCCCC | 66.22 | 21890473 | |
178 (in isoform 1) | Ubiquitination | - | 66.22 | 21890473 | |
179 | Ubiquitination | IIPQLKKKYDVDTLD HHHHHHHHCCCCCCC | 45.13 | 21890473 | |
179 (in isoform 1) | Ubiquitination | - | 45.13 | 21890473 | |
179 | Acetylation | IIPQLKKKYDVDTLD HHHHHHHHCCCCCCC | 45.13 | 27452117 | |
180 | Phosphorylation | IPQLKKKYDVDTLDM HHHHHHHCCCCCCCE | 30.03 | 20068231 | |
184 | Phosphorylation | KKKYDVDTLDMVFLD HHHCCCCCCCEEEHH | 25.22 | 20068231 | |
194 | Ubiquitination | MVFLDHWKDRYLPDT EEEHHHHHHCCCCCC | 28.98 | - | |
194 | 2-Hydroxyisobutyrylation | MVFLDHWKDRYLPDT EEEHHHHHHCCCCCC | 28.98 | - | |
197 | Phosphorylation | LDHWKDRYLPDTLLL HHHHHHCCCCCCHHH | 32.49 | 27422710 | |
201 | Phosphorylation | KDRYLPDTLLLEECG HHCCCCCCHHHHHHC | 19.84 | 27422710 | |
207 | Glutathionylation | DTLLLEECGLLRKGT CCHHHHHHCCCCCCC | 3.21 | 22833525 | |
209 (in isoform 2) | Ubiquitination | - | 6.72 | 21890473 | |
212 | 2-Hydroxyisobutyrylation | EECGLLRKGTVLLAD HHHCCCCCCCEEEEC | 59.92 | - | |
212 | Ubiquitination | EECGLLRKGTVLLAD HHHCCCCCCCEEEEC | 59.92 | 22053931 | |
213 (in isoform 2) | Ubiquitination | - | 18.02 | 21890473 | |
223 | Glutathionylation | LLADNVICPGAPDFL EEECCEECCCCCHHH | 1.90 | 22833525 | |
236 | Phosphorylation | FLAHVRGSSCFECTH HHHHHCCCCCCCCCC | 17.23 | 27251275 | |
237 | Phosphorylation | LAHVRGSSCFECTHY HHHHCCCCCCCCCCH | 26.16 | 27251275 | |
242 | Phosphorylation | GSSCFECTHYQSFLE CCCCCCCCCHHHHHH | 19.20 | 28796482 | |
244 | Phosphorylation | SCFECTHYQSFLEYR CCCCCCCHHHHHHHH | 6.41 | 28796482 | |
246 | Phosphorylation | FECTHYQSFLEYREV CCCCCHHHHHHHHHH | 25.32 | 28796482 | |
250 | Phosphorylation | HYQSFLEYREVVDGL CHHHHHHHHHHHHHH | 17.77 | 28152594 | |
259 | Acetylation | EVVDGLEKAIYKGPG HHHHHHHHHHHCCCC | 45.16 | 27452117 | |
259 (in isoform 1) | Ubiquitination | - | 45.16 | 21890473 | |
259 | 2-Hydroxyisobutyrylation | EVVDGLEKAIYKGPG HHHHHHHHHHHCCCC | 45.16 | - | |
259 | Ubiquitination | EVVDGLEKAIYKGPG HHHHHHHHHHHCCCC | 45.16 | 21890473 | |
262 | Phosphorylation | DGLEKAIYKGPGSEA HHHHHHHHCCCCCCC | 18.10 | 23403867 | |
263 | Ubiquitination | GLEKAIYKGPGSEAG HHHHHHHCCCCCCCC | 53.14 | 2190698 | |
263 (in isoform 1) | Ubiquitination | - | 53.14 | 21890473 | |
267 | Phosphorylation | AIYKGPGSEAGP--- HHHCCCCCCCCC--- | 27.66 | 23401153 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of COMT_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of COMT_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COMT_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PCH2_HUMAN | TRIP13 | physical | 16189514 | |
PCH2_HUMAN | TRIP13 | physical | 19060904 | |
KRA59_HUMAN | KRTAP5-9 | physical | 25416956 | |
K1H1_HUMAN | KRT31 | physical | 25416956 | |
PCH2_HUMAN | TRIP13 | physical | 25416956 | |
K1C40_HUMAN | KRT40 | physical | 25416956 | |
CO1A2_HUMAN | COL1A2 | physical | 26496610 | |
FGF2_HUMAN | FGF2 | physical | 26496610 | |
EXO1_HUMAN | EXO1 | physical | 26496610 | |
RIN1_HUMAN | RIN1 | physical | 26496610 | |
US6NL_HUMAN | USP6NL | physical | 26496610 | |
HIG1A_HUMAN | HIGD1A | physical | 26496610 | |
IPYR2_HUMAN | PPA2 | physical | 26496610 | |
ESYT1_HUMAN | ESYT1 | physical | 27173435 | |
TMX1_HUMAN | TMX1 | physical | 27173435 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
D00095 | Adrenaline (JP16); Epinephrine (USP/INN); Adrenalin (TN); Auvi-q (TN); Epipen (TN) |
D00152 | Phloroglucinol (JAN); Dilospan S (TN) |
D00633 | Dopamine hydrochloride (JP16/USP); Actopamin (TN); Intropin (TN) |
D00781 | Entacapone (JAN/USAN/INN); Comtan (TN) |
D00786 | Tolcapone (JAN/USAN/INN); Tasmar (TN) |
D01259 | Flopropione (JP16/INN); Ephtanon (TN) |
D03241 | Nitecapone (INN) |
D07870 | Dopamine (INN); Medopa (TN) |
D08369 | Polyphloroglucinol phosphate; Dealyd (TN) |
DrugBank | |
DB00286 | Conjugated Estrogens |
DB00255 | Diethylstilbestrol |
DB00841 | Dobutamine |
DB00988 | Dopamine |
DB00494 | Entacapone |
DB00968 | Methyldopa |
DB01141 | Micafungin |
DB00118 | S-Adenosylmethionine |
DB01420 | Testosterone Propionate |
DB00323 | Tolcapone |
loading...